News Headlines Article

Generic-drug user-fee program moving forward
Modern Healthcare

A user-fee program intended to speed the approval of generic drugs is expected to begin Oct. 1 as planned even though Congress and the president failed to reach a spending agreement that reflected the new initiative.

Legislation passed in both the House and Senate before Congress adjourned until after the election would allow the Food and Drug Administration to begin collecting user fees from the generic drug industry next year.